2013 – Customized Chemistry Services CRO, CreaGen Biosciences, Hails New Economical FTE Rates

December 28, 2013 by admin

December 29, 2013 (PressRelease) – Creagen Biosciences hails the success of its 10 year world-class services organization, is pleased to announce a competitive discounted rate for all future projects of 5 FTEs or greater during Q1 2014. “This special offer is our way of saying thanks to all our loyal patrons that have supported us during our first 10 years,” commented, Raj Rajur, CEO, President and Founder, CreaGen Biosciences.”

CreaGen is a trusted drug discovery chemistry specialty CRO and is a leading provider of medicinal chemistry, lead generation, lead optimization, scaffold/building blocks, parallel synthesis, and high throughput purification, “The authentic skills and experience required to run a high quality trusted organization like CreaGen is relatively rare. Our team routinely tackles the complex, tough chemistry that less skilled international organizations struggle at or labor over much longer than my skilled team. Our synthetic organic chemistry expertise and automated platform enable us to rapidly produce and purify the molecules needed for biological screening. We constantly adapt our services to meet the needs of our pharmaceutical and biotech customers, always with a focus on building long-term relationships, “Raj continues.

For companies seeking ways to streamline unnecessary overhead by eliminating global travel and cutting back on extended hours to oversee external projects, Creagen offers the industry higher quality discovery services at reduced rates. Recognized as the preferred contract research organization to top pharmaceutical and emerging companies, CreaGen offers a unique and flexible chemistry outsourcing experience and enjoys repeat business with more than 50 companies worldwide.

About CreaGen Biosciences

CreaGen Biosciences is a specialty drug discovery chemistry service company that provides high quality research support to biotech and pharmaceutical companies. The company’s discovery research service engine helps transform research ideas into innovative medicines, serving as a de facto medicinal chemistry facility for moving concepts to the clinic. CreaGen’s scientists are highly skilled with extensive experience in a broad range of therapeutic areas, offering partners an opportunity to expand their core business on a fast track while significantly reducing overhead costs. In addition, CreaGen’s ‘Chemistry Incubator Division’ offers for innovators a collaborative place to launch, incubate and grow their emerging life science companies. Recognized as the preferred contract research organization to top pharmaceutical and emerging companies and the only regional incubator dedicated to chemistry, CreaGen offers a unique and flexible chemistry experience and enjoys repeat business with more than 50 companies worldwide and has been the home to several emerging biotechs.

Press Contact:

ShelleyCo
44 Prairie Street
Concord, MA 01742
Phone: 978-239-1468
Email: shelley@shelleyco.com

General Contact:
CreaGen Biosciences, Inc.
Raj (SB) Rajur, Ph.D., President/CEO
23 Rainin Road Woburn, MA 01801
Phone: 781.938.1123 Cell: 978.764.7068

Email: rrajur@creageninc.com
www.creageninc.com

admin



Subscribe


Sign up for CreaGen Inc newsletter to receive all the news.




Social networks



Twitter

#WeCare




Contact us




Send us an email

rrajur@creageninc.com



Subscribe


Sign up for Medicare newsletter to receive all the news offers and discounts from Medicare eye clinic.




Social networks



Twitter

#WeCare





© CreaGen Inc 2019. All rights reserved. Designed by Inqude



© CreaGen Inc 2019. All rights reserved. Designed by Inqude